On the other hand, in U251 KO and U118 KO glioma cells, TP53 R273H mutation resulted in an upregulation of GPX4, which was reversed by siTP63 treatment (Fig. 5E–H). The gene discussed is GPX4; the disease is central nervous system cancer.